4.7 Article

Antibacterial activities of gold and silver nanoparticles against Escherichia coli and bacillus Calmette-Guerin

Journal

JOURNAL OF NANOBIOTECHNOLOGY
Volume 10, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/1477-3155-10-19

Keywords

Antibacterial effect; Gold; Silver; Nanoparticle; BCG

Funding

  1. National Science Foundation [0506082]
  2. Bill and Melinda Gates Foundation [48523]
  3. Directorate For Engineering
  4. Div Of Civil, Mechanical, & Manufact Inn [0506082] Funding Source: National Science Foundation

Ask authors/readers for more resources

Background: Diseases such as tuberculosis (TB) have always had a large impact on human health. Bacillus Calmette-Guerin (BCG) is used as a surrogate for TB during the development of anti-TB drugs. Nanoparticles (NPs) have attracted great interest in drug development. The purpose of this study was to examine the potential of NPs as anti-TB compounds by studying the interacting mechanisms between NPs and bacteria. Results: We investigated effects of gold and silver NPs on BCG and Escherichia coli. Experimentally, particle size and shape were characterized using transmission electron microscopy (TEM). Different concentrations of NPs were applied in bacterial culture. The growth of E. coli was monitored through colony forming units (CFU). The mechanism of interaction between NPs and bacteria was analyzed through bacterial thin sections followed by TEM and scanning electron microscopy. Antibacterial effects on BCG were observed by recording fluorescent protein expression levels. Conclusions: The results suggest NPs have potential applications as anti-TB compounds. The antibacterial effects and mechanism of action for NPs were dependent upon composition and surface modifications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available